FDA Authorizes Yale’s SalivaDirect '$10' Rapid COVID-19 Test
The agency says the test is “groundbreaking.” The Yale School of Public Health is giving away the test methodology, which can be run with equipment labs already have.
You may also be interested in...
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
A new template from the US FDA explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.
The company stopped shipping Alaris in early 2020 after the FDA requested a new 510(k) for modifications and the device has been the subject of several recalls since then.